Researchers have found that low-intensity sound waves directed through the skull can help mice shed conditioned fear responses, offering a potential new route for treating trauma-related disorders. A study published in NeuroImage on October 1, 2025, showed that transcranial ultrasound stimulation applied to the prefrontal cortex promoted the extinction of fear memory in mice, and the team traced the effect to a specific molecular signaling pathway. The findings arrive as transcranial ultrasound gains traction across neuroscience labs worldwide, though significant hurdles remain before the technique could reach human clinics.
How Sound Waves Rewired Fear Circuits in Mice
The core experiment was straightforward in design but technically demanding. Researchers conditioned mice to associate a harmless cue with a mild foot shock, creating a measurable fear response. They then applied low-intensity ultrasound to the prefrontal cortex and tracked what happened at both the behavioral and cellular level. Mice that received the ultrasound showed reduced conditioned fear responses and faster extinction of the fear memory compared with controls.
What sets this study apart from earlier work is the mechanistic detail. The team used two-photon imaging to observe dendritic spine formation and elimination in the prefrontal cortex in real time, providing direct visual evidence that the ultrasound was reshaping neural connections. The study, which is indexed in PubMed, identified the BDNF-TrkB signaling pathway as the molecular engine driving these changes. Prior to this work, the mechanism by which transcranial ultrasound promoted fear extinction had remained unclear, leaving open questions about how a mechanical stimulus at the skull could produce lasting changes in synaptic strength.
By combining behavioral testing, in vivo imaging and molecular assays, the researchers were able to show that repeated ultrasound sessions increased BDNF expression and TrkB activation specifically in prefrontal neurons that were engaged during fear extinction. Blocking TrkB signaling pharmacologically largely abolished the behavioral benefit, strengthening the case that this pathway is not just correlated with, but required for, the ultrasound effect. Together, the data suggest that sound waves can bias plasticity in a circuit that arbitrates between threat and safety responses.
Why BDNF-TrkB Matters for Fear Extinction
Brain-derived neurotrophic factor, or BDNF, is a protein that supports the growth and survival of neurons. Its receptor, TrkB, acts as a lock that BDNF fits into to trigger downstream changes in neural plasticity. Earlier research established that BDNF signaling in the amygdala is necessary for consolidation of extinction memory. That foundational work used viral approaches to disrupt TrkB signaling, showing that blocking the receptor impaired the brain’s ability to store the new “safe” memory without affecting the initial encoding of fear.
The new ultrasound study builds on that foundation by showing the same pathway can be activated noninvasively from outside the skull. Separate rodent research has demonstrated that BDNF activity in the infralimbic cortex can be sufficient to reduce freezing behavior even for older fear memories, pointing to a critical role for this prefrontal region in updating threat assessments. And the picture is not uniform across the prefrontal cortex: work published in the Proceedings of the National Academy of Sciences found that prelimbic BDNF is required for memory of learned fear but not for extinction or innate fear.
That anatomical distinction matters because it implies that ultrasound targeting must be precise. Stimulating the wrong subregion could, in theory, strengthen a fear memory rather than weaken it by boosting plasticity in circuits that encode threat instead of safety. The mouse study used careful stereotaxic alignment and acoustic modeling to focus energy on the infralimbic homolog, but translating that precision to human skulls, with their thicker bone and more variable geometry, will be a major technical challenge.
Fear Extinction Is Not the Same as Forgetting
A common misconception is that fear extinction erases the original memory. It does not. As Nature coverage of related mouse research has emphasized, extinction means overwriting or suppressing fear responses after danger passes. The original fear trace remains in the brain, but a new competing memory forms that signals the threat is gone. This helps explain why people with post-traumatic stress disorder can relapse: the suppressive memory weakens, and the old fear reasserts itself.
Neuroscientists have begun to map the circuits that implement this competition. Researchers at the University of Chicago, for example, identified a pathway that reduces inappropriate fear responses to non-dangerous situations and accelerates extinction learning. In that work, prefrontal projections helped tune amygdala activity so that cues no longer associated with harm stopped triggering defensive reactions.
The ultrasound findings fit neatly into this broader picture. If transcranial stimulation can selectively boost BDNF-TrkB signaling in the right prefrontal region, it may strengthen the competing “safe” memory and make extinction more durable. Rather than deleting traumatic experiences, such an intervention would aim to rebalance how the brain weighs old danger signals against new evidence of safety, potentially complementing exposure-based psychotherapies.
Early Human Experiments Show Promise and Limits
The mouse results do not exist in isolation. Several groups have begun testing transcranial ultrasound in human volunteers. According to a study in Brain Stimulation, a randomized, double-blind experiment used active versus sham focused ultrasound targeting the left amygdala during a fear-inducing task. The researchers measured pre- and post-stimulation responses using fMRI, skin conductance and self-reported anxiety, and reported decreased amygdala activation and altered connectivity within the broader fear network.
A separate pilot protocol described in a small imaging study also measured pre- and post-stimulation fMRI responses to threatening faces and found decreased amygdala activation. That study, however, acknowledged limitations including the lack of a sham control, which makes it harder to rule out placebo effects or habituation to repeated scanning. The contrast between the two designs highlights a tension in the field: the randomized trial included a sham condition, while the pilot did not, and both claim reduced amygdala reactivity. Readers should weigh the sham-controlled evidence more heavily until larger trials confirm the open-label findings.
Even in the more rigorous trial, the behavioral impact on subjective fear and physiological arousal was modest, and follow-up was short. The experiments were conducted in healthy volunteers during laboratory tasks, not in patients with chronic trauma-related disorders. As a result, they offer a proof of principle that ultrasound can modulate deep-brain circuits involved in fear, but they do not yet demonstrate durable clinical benefit.
Safety, Specificity and the Road to the Clinic
For ultrasound neuromodulation to move from research labs into routine psychiatric care, several hurdles must be cleared. Safety is the first concern. Low-intensity protocols like those used in the mouse extinction study and early human work are far below levels used for ablative procedures, but regulators will want extensive data on potential cumulative effects, especially with repeated sessions. The fact that the new preclinical work ties behavioral changes to a defined molecular cascade provides some reassurance that the intervention is acting through known plasticity pathways rather than uncontrolled tissue damage.
Specificity is the second challenge. Human skull thickness, individual differences in anatomy and the complex folding of the cortex all complicate efforts to target infralimbic or amygdala subregions with millimeter precision. Researchers are developing real-time acoustic modeling and MRI-guided targeting to narrow the focus of stimulation, but these tools remain largely confined to specialized centers. As Nature’s subscriber portal for neuroscience coverage underscores, translating cutting-edge circuit work into scalable interventions is rarely straightforward.
A third issue is individual variability in plasticity. Genetic differences in BDNF and TrkB, prior stress history and concurrent medications could all shape how a person’s brain responds to ultrasound. Early pharmacogenetic studies, some catalogued through NCBI records, have shown that BDNF polymorphisms can alter synaptic remodeling and fear learning. Future ultrasound trials may need to stratify participants by such factors or combine stimulation with drugs that modulate neurotrophin signaling.
For now, the new mouse data offer a compelling mechanistic bridge between sound waves at the skull and molecular events at synapses. By showing that low-intensity ultrasound can engage BDNF-TrkB signaling to remodel prefrontal circuits and accelerate fear extinction, the work strengthens the rationale for cautious clinical exploration. But it also underscores that any therapeutic use will have to respect the complexity of fear circuitry: extinction is not erasure, and pushing plasticity in the wrong place or at the wrong time could backfire. The next phase of research will test whether the same carefully tuned approach that worked in mice can help people whose lives are dominated by memories that their brains cannot easily let go.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
